Handelsbanken Fonder AB »

Catalyst Pharmaceutical Partners shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2024-03-31 $403k 25k 15.94
2023-12-31 $425k 25k 16.81
2023-09-30 $326k 28k 11.69
2023-06-30 $195k 15k 13.45

More positions owned by Handelsbanken Fonder AB

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
UnitedHealth (UNH)
Alphabet Inc Class C cs (GOOG)
Broadcom (AVGO)
MasterCard Incorporated (MA)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Thermo Fisher Scientific (TMO)
Abbott Laboratories (ABT)
Johnson & Johnson (JNJ)

View all positions for Handelsbanken Fonder AB

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners